Annual Cash & Cash Equivalents
$12.89 M
+$6.74 M+109.45%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual cash & cash equivalents is $12.89 million, with the most recent change of +$6.74 million (+109.45%) on December 31, 2023.
- During the last 3 years, ELTX annual cash & cash equivalents has fallen by -$2.07 million (-13.85%).
- ELTX annual cash & cash equivalents is now -13.85% below its all-time high of $14.97 million, reached on December 31, 2020.
Performance
ELTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$26.02 M
+$22.59 M+659.59%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly cash and cash equivalents is $26.02 million, with the most recent change of +$22.59 million (+659.59%) on September 30, 2024.
- Over the past year, ELTX quarterly cash and cash equivalents has increased by +$11.18 million (+75.30%).
- ELTX quarterly cash and cash equivalents is now at all-time high.
Performance
ELTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +109.5% | +75.3% |
| 3 y3 years | -13.8% | - |
| 5 y5 years | +89.3% | - |
ELTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +109.5% | at high | +659.6% |
| 5 y | 5-year | -13.8% | +109.5% | at high | +659.6% |
| alltime | all time | -13.8% | +109.5% | at high | +659.6% |
Elicio Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.02 M(+659.6%) |
| Jun 2024 | - | $3.42 M(-71.1%) |
| Mar 2024 | - | $11.85 M(-8.1%) |
| Dec 2023 | $12.89 M | $12.89 M(-13.1%) |
| Sep 2023 | - | $14.84 M(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $21.68 M(+252.2%) |
| Dec 2022 | $6.16 M(-33.7%) | $6.16 M(-55.8%) |
| Dec 2021 | $9.28 M(-38.0%) | - |
| Mar 2021 | - | $13.93 M |
| Dec 2020 | $14.97 M(+119.8%) | - |
| Dec 2019 | $6.81 M | - |
FAQ
- What is Elicio Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Elicio Therapeutics?
- What is Elicio Therapeutics annual cash & cash equivalents year-on-year change?
- What is Elicio Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Elicio Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ELTX is $12.89 M
What is the all time high annual cash & cash equivalents for Elicio Therapeutics?
Elicio Therapeutics all-time high annual cash & cash equivalents is $14.97 M
What is Elicio Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ELTX annual cash & cash equivalents has changed by +$6.74 M (+109.45%)
What is Elicio Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELTX is $26.02 M
What is the all time high quarterly cash and cash equivalents for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly cash and cash equivalents is $26.02 M
What is Elicio Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ELTX quarterly cash and cash equivalents has changed by +$11.18 M (+75.30%)